ANS-6637
N/A
Report date: 2024/12/30 20:00:41
NME
Base Information
Drug NameANS-6637
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGilead Inc
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesNational Institutes Of Health Clinical Center (Cc)National Institute On Alcohol Abuse And AlcoholismAmygdala Neurosciences Inc +[5]
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A